AccessPak for HIV PEP Expanded with Kaletra and Theophylline in Dextrose
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Theophylline in Dextrose and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using ritonavir together with theophylline may decrease the effects of theophylline. Contact your doctor if your condition changes or if you experience breathing difficulties. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: The coadministration with ritonavir may decrease the plasma concentrations of theophylline. The proposed mechanism is ritonavir induction of CYP450 1A2, the isoenzyme responsible for the metabolic clearance of theophylline. In a study involving 27 subjects, ritonavir (500 mg orally every 12 hours for 10 days) decreased the steady-state peak plasma concentration (Cmax), area under the concentration-time curve (AUC), and trough concentration (Cmin) of theophylline (3 mg/kg every 8 hours) by 32%, 43%, and 57%, respectively, compared to placebo. The half-life also decreased from 8.4 hours at baseline to 3.6 hours after 10 days of ritonavir.
MANAGEMENT: During coadministration with ritonavir, the possibility of a diminished therapeutic response to theophylline should be considered. Dosage adjustment as well as clinical and laboratory monitoring may be appropriate whenever ritonavir is added to or withdrawn from therapy.
- "Product Information. Norvir (ritonavir)." Abbott Pharmaceutical, Abbott Park, IL.
- Hsu A, Granneman GR, Witt G, Cavanaugh JH, Leonard J "Assessment of multiple doses of ritonavir on the pharmacokinetics of theophylline." Int Conf AIDS 11 (1996): 89(ab.no.mo.b.1200)
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: theophylline
Brand name: Elixophyllin, Theo-24, Respbid, T-Phyl, Aerolate III, Slo-Bid Gyrocaps, Slo-Phyllin, Theobid, Theo-Dur, Theolair, Theovent, Bronkodyl, Theo-X, Theo-Time, Theochron, Slo-Phyllin 125, Theoclear LA-130, Aerolate JR, Theolair-SR, Theoclear LA-260, Quibron-T, Quibron-T/SR, Uniphyl, Uni-Dur, Aerolate SR, Slo-Phyllin 80, Theoclear-80, Theo-Dur Sprinkles, Theosol-80, Asmalix, Aquaphyllin, Truxophyllin, Slo-Phyllin 250, TheoCap
Synonyms: Theophylline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Theophylline Injection
- AccessPak for HIV PEP Expanded with Kaletra-Theophylline Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Theophylline Liquid
- AccessPak for HIV PEP Expanded with Kaletra-Theophylline Oral Solution
- AccessPak for HIV PEP Expanded with Kaletra-Theophylline Sustained-Release Capsules
- AccessPak for HIV PEP Expanded with Kaletra-Theophylline Sustained-Release Tablets
- Theophylline in Dextrose-AccessPak for HIV PEP Expanded with Viracept
- Theophylline in Dextrose-Accolate
- Theophylline in Dextrose-Accretropin
- Theophylline in Dextrose-Accucaine
- Theophylline in Dextrose-AccuHist Drops
- Theophylline in Dextrose-AccuHist PDX Drops